Literature DB >> 30344053

Thioglycosides Are Efficient Metabolic Decoys of Glycosylation that Reduce Selectin Dependent Leukocyte Adhesion.

Shuen-Shiuan Wang1, Xuefeng Gao2, Virginia Del Solar3, Xinheng Yu1, Aristotelis Antonopoulos4, Alan E Friedman5, Eryn K Matich5, G Ekin Atilla-Gokcumen5, Mehrab Nasirikenari6, Joseph T Lau6, Anne Dell4, Stuart M Haslam4, Roger A Laine2, Khushi L Matta7, Sriram Neelamegham8.   

Abstract

Metabolic decoys are synthetic analogs of naturally occurring biosynthetic acceptors. These compounds divert cellular biosynthetic pathways by acting as artificial substrates that usurp the activity of natural enzymes. While O-linked glycosides are common, they are only partially effective even at millimolar concentrations. In contrast, we report that N-acetylglucosamine (GlcNAc) incorporated into various thioglycosides robustly truncate cell surface N- and O-linked glycan biosynthesis at 10-100 μM concentrations. The >10-fold greater inhibition is in part due to the resistance of thioglycosides to hydrolysis by intracellular hexosaminidases. The thioglycosides reduce β-galactose incorporation into lactosamine chains, cell surface sialyl Lewis-X expression, and leukocyte rolling on selectin substrates including inflamed endothelial cells under fluid shear. Treatment of granulocytes with thioglycosides prior to infusion into mouse inhibited neutrophil homing to sites of acute inflammation and bone marrow by ∼80%-90%. Overall, thioglycosides represent an easy to synthesize class of efficient metabolic inhibitors or decoys. They reduce N-/O-linked glycan biosynthesis and inflammatory leukocyte accumulation.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  N-glycan; decoy; fluid shear; glycosides; glycosylation; inflammation; leukocyte-endothelial adhesion; selectins; small-molecule inhibitors; thioglycoside

Mesh:

Substances:

Year:  2018        PMID: 30344053      PMCID: PMC6474417          DOI: 10.1016/j.chembiol.2018.09.012

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  48 in total

1.  Purification of Bacillus pumilus beta-D-xylosidase by affinity chromatography.

Authors:  M Claeyssens; H Kersters-Hilderson; J -P. Van Wauwe; C K. De Bruyne
Journal:  FEBS Lett       Date:  1970-12-18       Impact factor: 4.124

2.  Fucosylation of disaccharide precursors of sialyl LewisX inhibit selectin-mediated cell adhesion.

Authors:  A K Sarkar; K S Rostand; R K Jain; K L Matta; J D Esko
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

3.  Specificity of β1,4-galactosyltransferase inhibition by 2-naphthyl 2-butanamido-2-deoxy-1-thio-β-D-glucopyranoside.

Authors:  Yin Gao; Carmen Lazar; Walter A Szarek; Inka Brockhausen
Journal:  Glycoconj J       Date:  2010-10-26       Impact factor: 2.916

4.  Synthesis of 2-acetamido-2-deoxy-1-thio-beta-D-glucopyranosides.

Authors:  K L Matta; E A Johnson; R N Girotra; J J Barlow
Journal:  Carbohydr Res       Date:  1973-10       Impact factor: 2.104

5.  The influence of p-nitrophenyl beta-d-xyloside on the synthesis of proteochondroitin sulfate by slices of embryonic chick cartilage.

Authors:  M Okayama; K Kimata; S Suzuki
Journal:  J Biochem       Date:  1973-11       Impact factor: 3.387

6.  Selectin catch-bonds mechanotransduce integrin activation and neutrophil arrest on inflamed endothelium under shear flow.

Authors:  Vasilios A Morikis; Shannon Chase; Ted Wun; Elliot L Chaikof; John L Magnani; Scott I Simon
Journal:  Blood       Date:  2017-08-15       Impact factor: 22.113

7.  Competition between core-2 GlcNAc-transferase and ST6GalNAc-transferase regulates the synthesis of the leukocyte selectin ligand on human P-selectin glycoprotein ligand-1.

Authors:  Chi Y Lo; Aristotelis Antonopoulos; Rohitesh Gupta; Jun Qu; Anne Dell; Stuart M Haslam; Sriram Neelamegham
Journal:  J Biol Chem       Date:  2013-04-02       Impact factor: 5.157

8.  UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase--a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme.

Authors:  Inka Brockhausen; Melinda Benn; Shridhar Bhat; Sandra Marone; John G Riley; Pedro Montoya-Peleaz; Jason Z Vlahakis; Hans Paulsen; John S Schutzbach; Walter A Szarek
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

9.  Inhibition of glycosylation by amphomycin and sugar nucleotide analogs PP36 and PP55 indicates that Haloferax volcanii beta-glucosylates both glycoproteins and glycolipids through lipid-linked sugar intermediates: evidence for three novel glycoproteins and a novel sulfated dihexosyl-archaeol glycolipid.

Authors:  B C Zhu; R R Drake; H Schweingruber; R A Laine
Journal:  Arch Biochem Biophys       Date:  1995-06-01       Impact factor: 4.013

Review 10.  Glycotherapy: new advances inspire a reemergence of glycans in medicine.

Authors:  Jason E Hudak; Carolyn R Bertozzi
Journal:  Chem Biol       Date:  2013-11-21
View more
  11 in total

1.  Robustness in glycosylation systems: effect of modified monosaccharides, acceptor decoys and azido sugars on cellular nucleotide-sugar levels and pattern of N-linked glycosylation.

Authors:  Virginia Del Solar; Rohitesh Gupta; Yusen Zhou; Gabrielle Pawlowski; Khushi L Matta; Sriram Neelamegham
Journal:  Mol Omics       Date:  2020-04-30

2.  Comparative Glycomics Analysis of Mass Spectrometry Data.

Authors:  Yusen Zhou; Sriram Neelamegham
Journal:  Methods Mol Biol       Date:  2022

3.  Forward Genetic Screens of Human Glycosylation Pathways Using the GlycoGene CRISPR Library.

Authors:  Anju Kelkar; Theodore Groth; Sriram Neelamegham
Journal:  Curr Protoc       Date:  2022-04

4.  Efficient inhibition of O-glycan biosynthesis using the hexosamine analog Ac5GalNTGc.

Authors:  Shuen-Shiuan Wang; Virginia Del Solar; Xinheng Yu; Aristotelis Antonopoulos; Alan E Friedman; Kavita Agarwal; Monika Garg; Syed Meheboob Ahmed; Ahana Addhya; Mehrab Nasirikenari; Joseph T Lau; Anne Dell; Stuart M Haslam; Srinivasa-Gopalan Sampathkumar; Sriram Neelamegham
Journal:  Cell Chem Biol       Date:  2021-02-19       Impact factor: 8.116

Review 5.  Glycosylation in health and disease.

Authors:  Colin Reily; Tyler J Stewart; Matthew B Renfrow; Jan Novak
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 42.439

6.  The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.

Authors:  Roger A Laine
Journal:  Glycobiology       Date:  2020-09-28       Impact factor: 4.313

Review 7.  Glycosylation in the Tumor Microenvironment: Implications for Tumor Angiogenesis and Metastasis.

Authors:  Kevin Brown Chandler; Catherine E Costello; Nader Rahimi
Journal:  Cells       Date:  2019-06-05       Impact factor: 6.600

Review 8.  Don't sugarcoat it: How glycocalyx composition influences cancer progression.

Authors:  Alexander Buffone; Valerie M Weaver
Journal:  J Cell Biol       Date:  2020-01-06       Impact factor: 10.539

9.  Metabolic inhibitors of bacterial glycan biosynthesis.

Authors:  Daniel A Williams; Kabita Pradhan; Ankita Paul; Ilana R Olin; Owen T Tuck; Karen D Moulton; Suvarn S Kulkarni; Danielle H Dube
Journal:  Chem Sci       Date:  2020-01-08       Impact factor: 9.969

Review 10.  Cell-Free Synthetic Glycobiology: Designing and Engineering Glycomolecules Outside of Living Cells.

Authors:  Thapakorn Jaroentomeechai; May N Taw; Mingji Li; Alicia Aquino; Ninad Agashe; Sean Chung; Michael C Jewett; Matthew P DeLisa
Journal:  Front Chem       Date:  2020-07-29       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.